Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Consolidated Statements of Operations [Abstract]        
Revenue $ 1,250,515 $ 2,113,003 $ 3,452,067 $ 7,732,313
Cost of sales 935,379 1,456,946 3,830,215 5,582,692
Gross profit (loss) 315,136 656,057 (378,148) 2,149,621
Operating expenses:        
Selling, general and administrative 899,116 1,432,920 3,854,782 4,654,095
Research and development 125,924 214,116 448,920 631,799
Impairment charge     3,397,212  
Total operating expenses 1,025,040 1,647,036 7,700,914 5,285,894
Operating loss (709,904) (990,979) (8,079,062) (3,136,273)
Non-operating income (expense):        
Interest expense (79,452) (41,576) (210,014) (97,198)
Gain on debt restructuring 1,048,308   1,048,308  
Other income 17 85 107 489
Total non-operating income (expense), net 968,873 (41,491) 838,401 (96,709)
Income (loss) from continuing operations 258,969 (1,032,470) (7,240,661) (3,232,982)
Discontinued operations:        
Income from discontinued operations    3,272 683 7,102
Net income (loss) 258,969 (1,029,198) (7,239,978) (3,225,880)
Accretion of preferred stock beneficial conversion feature (5,195,225)   (5,195,225)  
Net loss attributable to common stockholders $ (4,936,256) $ (1,029,198) $ (12,435,203) $ (3,225,880)
Basic and diluted loss per common share:        
Loss from continuing operations attributable to common stockholders $ (0.30) $ (0.06) $ (0.75) $ (0.20)
Discontinued operations $ 0.00 $ 0.00 $ 0.00 $ 0.00
Net loss attributable to common stockholders $ (0.30) $ (0.06) $ (0.75) $ (0.20)
Basic and diluted weighted average shares outstanding 16,517,955 16,452,738 16,474,716 16,389,967